Asia regional support letter for inclusion of Daclatasvir in WHO Model list of Essential Medicines

March 4, 2015 – Regional advocacy platform for access to Hep C treatment in Asia Pacific wrote to The Secretary of the 20th Expert Committee on the Selection and Use of Essential Medicines supporting MSF’s application to include Daclatasvir in the Model List of Essential Medicines of the World Health  Organisation (WHO)…read full letter